RESOURCES
Research Library
Every intelligence brief ChemLifeIntel publishes, organised across four disciplines and linked to the companies, molecules, facilities and regulators it covers — 900+ briefs and counting.
900+
Intelligence briefs
4
Intelligence disciplines
8,000+
Entities linked
Daily
New analysis
Regulatory Intelligence
Warning letters, 483s, import alerts, approvals and enforcement across global authorities.
Trade & Supply Chain
HSN-coded trade flows, export shifts and supply disruptions across the value chain.
Market Intelligence
Price movements, capacity changes, market entries and competitive dynamics.
Clinical & Pipeline
Phase readouts, approvals, patent cliffs and pipeline milestones.
Recent analysis
Browse the ExplorerCDSCO Enacts Sweeping Regulatory Changes Across India's Pharma and Medical Device Sectors
REGULATORY INTELLIGENCE · 3h ago
ANSM Fines Novo Nordisk and Eli Lilly for GLP-1 Obesity Campaign Breaches, Novo Nordisk Explores Legal Challenge
REGULATORY INTELLIGENCE · 4h ago
Kardigan's $400M IPO Fuels Cardiovascular Drug Development Amid Biotech Funding Surge
MARKET INTELLIGENCE · 4h ago
Spero Therapeutics and GSK Secure FDA Approval for Oral cUTI Treatment Utebzi After Four-Year Regulatory Journey
CLINICAL & PIPELINE · 9h ago
GSK Elevates Exdensur with Direct-to-Consumer Campaign, Signaling Blockbuster Ambitions in Asthma Market
MARKET INTELLIGENCE · 9h ago
Verastem Oncology Reprioritizes R&D, Shifting Focus from Avutometinib and Defactinib Combo in Pancreatic Cancer
TRADE & SUPPLY CHAIN · 9h ago
Boston University's SLATE Study Completes, Signaling Shift in Global HIV Antiretroviral Therapy Initiation Protocols
CLINICAL & PIPELINE · 11h ago
FDA Faces Pressure to Restrict Livestock Antibiotic Use: Major Commercial Implications for Chemical and Life Sciences
REGULATORY INTELLIGENCE · 13h ago
Cairo University Completes Clinical Study NCT06069635 on Fatigue and Performance in Adolescent Football Players
CLINICAL & PIPELINE · 13h ago
J&J's MonumenTAL-3 Phase 3 Data for Talvey and Darzalex Faspro Signals Major Shift in Earlier Multiple Myeloma Treatment
CLINICAL & PIPELINE · 13h ago
Jazz Pharmaceuticals' $4 Billion AbCellera Deal Ignites Next-Gen T-Cell Engager Race for Solid Tumors
MARKET INTELLIGENCE · 14h ago
Sanofi Secures FDA Expansion for Type 1 Diabetes Drug Tzield, Boosting Market Access
MARKET INTELLIGENCE · 15h ago
CinnaGen's Zandoriah®: First EU Authorization for Teriparatide Biosimilar in Osteoporosis Across 30 EEA States
CLINICAL & PIPELINE · 15h ago
Germany Abandons Branded Pharmaceutical Price Reduction Plan Amid Industry Opposition
REGULATORY INTELLIGENCE · 17h ago
Moderna Restructures Leadership for 2027-2028 Product Launches: Key Implications for Supply Chain and Regulatory Affairs
MARKET INTELLIGENCE · 17h ago
Jazz Pharmaceuticals Forges Strategic Oncology Alliance with AbCellera for Next-Generation Multispecific Antibodies
MARKET INTELLIGENCE · 17h ago
WHO Strengthens Global Clinical Trial Transparency and Good Practices: Implications for Pharma Supply Chains
CLINICAL & PIPELINE · 18h ago
Strategic Imperative: Leveraging FDA Orange Book Data Files for Chemical and Life Sciences Market Intelligence
CLINICAL & PIPELINE · 18h ago
Health Canada's Drug Product Database: A Critical Resource for Market Intelligence and Regulatory Compliance
REGULATORY INTELLIGENCE · 18h ago
FDA Enhances Drug Master File Reviews Under GDUFA III: Strategic Implications for API Supply and Generic Market Access
CLINICAL & PIPELINE · 18h ago
CDSCO Authorizes Oseltamivir Outlets: Clarifying India's Supply Channels for H1N1 Antivirals
REGULATORY INTELLIGENCE · 18h ago
TG Therapeutics Halts Phase 1b Trial for Novel CD47/CD19 Bispecific TG-1801 in B-Cell Lymphoma and CLL
CLINICAL & PIPELINE · 18h ago
Inhibrx Biosciences' Ozekibart BLA Acceptance Signals New Treatment Horizon for Chondrosarcoma
CLINICAL & PIPELINE · 18h ago
FiberSense Secures CE Mark for CGM System: Strategic Entry into European Diabetes Management Market
CLINICAL & PIPELINE · 19h ago
Vedana Therapeutics Secures $46M to Advance Anti-PACAP Migraine Therapies, Reshaping Treatment Landscape
MARKET INTELLIGENCE · 20h ago
Edgewise Therapeutics' EDG-7500 Phase 2 Data Shows Strong Efficacy in Hypertrophic Cardiomyopathy
CLINICAL & PIPELINE · 21h ago
Altaris Acquires Simulations Plus for $375M: Reshaping Computational Drug Discovery Landscape
MARKET INTELLIGENCE · 22h ago
Merck's $510M Protillion Deal Signals Major AI Shift in Biologics Discovery
MARKET INTELLIGENCE · 23h ago
Eli Lilly's Strategic Acquisition of 4E Therapeutics Bolsters Non-Opioid Pain Pipeline with MNK Inhibitors
MARKET INTELLIGENCE · 2d ago
Express Scripts, PCMA Challenge Tennessee's FAIR Rx Act: PBM Vertical Integration Under Threat
REGULATORY INTELLIGENCE · 2d ago
Moderna's mFlusiva Flu Vaccine Faces Intense FDA Scrutiny Ahead of Pivotal Advisory Panel Vote
CLINICAL & PIPELINE · 2d ago
Neumora Halts Navacaprant Depression Program After Phase 3 Failure: Market Repercussions
TRADE & SUPPLY CHAIN · 2d ago
Edgewise Therapeutics' EDG-7500 Phase 2 Data Signals Strong Competitive Entry in Hypertrophic Cardiomyopathy Market
CLINICAL & PIPELINE · 2d ago
Novo Nordisk Accelerates Wegovy Launch in China Amidst Patent Expiry and Eli Lilly Rivalry
MARKET INTELLIGENCE · 2d ago
GLP-1 Persistence Study Reveals Critical Discontinuation and Reinitiation Trends for Type 2 Diabetes Management
CLINICAL & PIPELINE · 2d ago
Neumora's Navacaprant Phase 3 Failure Reshapes Major Depressive Disorder Pipeline and Kappa Opioid Receptor Strategy
CLINICAL & PIPELINE · 2d ago
Request Terminal access
Unlock full briefs, entity dossiers and the 5-year compliance footprint.